Press release
With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”.
For more information please click on the following -
https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of companies engaged in the development of stem cell therapies for treatment of wide range of clinical conditions
Elaborate profiles of key industry players engaged in the development of stem cell therapies (shortlisted on the basis of the product portfolio).
An insightful competitiveness analysis featuring a four-dimensional bubble chart, highlighting the key players in this domain.
An assessment of over 20 commonly targeted therapeutic areas and details of stem cell-based therapies being developed to treat the same conditions.
A detailed proprietary 2×2 representation that was developed to assess the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.
An in-depth analysis of more than 1,500 grants that have been awarded to research institutes engaged in stem cell therapy-related projects, in the period between 2015 and 2019 (till November)
A detailed clinical trial analysis on more than 540 completed, ongoing and planned studies of various stem cell therapies, highlighting prevalent trends across various relevant parameters.
A review of the key aspects related to the manufacturing of stem cell therapies, including [A] a detailed discussion on processes and protocols, highlighting the need to outsource various aspects of stem cell therapy development and manufacturing operations, [B] an assessment of the current market landscape of contract manufacturers, providing information on stem cell-focused service providers, and [C] an insightful Harvey ball analysis to identify the key performance indicators / key considerations that industry stakeholders are likely to take into consideration while selecting a suitable CMO / CRO partner.
A detailed market gap analysis in order to develop a realistic understanding of the demand and supply dynamics within this field, comparing both clinical and commercial capabilities of therapy developers and the availability and capabilities of contract manufacturers, across different geographies.
An elaborate discussion on the various strategies that can be adopted by stem cell therapy developers across different stages of product development and commercialization.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Source of Stem Cell
Allogeneic
Autologous
Origin of Stem Cell
Adult
Embryonic
Type of Stem Cell
Hematopoietic
Mesenchymal
Progenitor
Others
Lineage of Stem Cell
Adipose Tissue
Bone Marrow
Cord Blood
Others
Route of Administration
Intraarticular
Intracoronary
Intramuscular
Intramyocardial
Intrathecal
Intravenous
Surgical Implantations
Others
Therapeutic Area
Autoimmune / Inflammatory Disorder
Cardiovascular Disorders
Metabolic Disorder
Musculoskeletal Disorders
Oncological Disorders
Neurological Disorders
Ophthalmic Disorders
Others
End Users
Ambulatory Surgery Centers
Hospitals
Specialty Clinics
Key Geographical Regions
North America
Europe
Asia-Pacific and Rest of the World
Transcripts of interviews held with the following senior level representatives of stakeholder companies
William L Rust (Founder and Chief Executive Officer, Seraxis)
Xuejun Huang Parsons (Chief Executive Officer, Xcelthera)
Michel Revel (Co-Founder and Chief Scientist, Kadimastem) and Galit Mazooz-Perlmuter (Director, Business Development, Kadimastem)
Kikuo Yasui (Director and Chief Operating Officer, Heartseed)
Gustav Steinhoff (Director and Chairman, Department of Cardiac Surgery, University of Rostock)
Gilles Devillers (President, Bio Elpida)
Fiona Bellot (Business Development Manager, Roslin Cell Therapies)
David Mckenna (Professor and American Red Cross Chair in Transfusion Medicine, University of Minnesota)
Brian Dattilo (Manager of Business Development, Waisman Biomanufacturing)
Mathilde Girard (Department Leader, Cell Therapy Innovation and Development, YposKesi)
Key companies covered in the report
Anterogen
Athersys
CHABiotech
Cytopeutics
Hope Biosciences
Japan Regenerative Medicine
Lineage Cell Therapeutics
Orchard Therapeutics
Osiris Therapeutics
Pluristem Therapeutics
Promithera Biosciences
Regenexx
Stempeutics Research
SCM Life Sciences
TICEBA
For more information please click on the following -
https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/
Other Recent Offerings
1. Stem Cell Therapy Contract Manufacturing Market, 2019-2030
2. Antibody Drug Conjugates Market (5th Edition), 2019-2030
3. Cell and Advanced Therapies Supply Chain Management Market, 2019-2030: Focus on Technological Solutions
4. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis here
News-ID: 2257068 • Views: …
More Releases from Roots Analysis
Pharmacy Market Size to Hit USD 4.1 Tillion by 2035 | Exclusive Report by Roots …
The global pharmacy market, valued at USD 2.4 trillion in 2024, is estimated to reach USD 2.5 trillion in 2025 and USD 4.1 trillion by 2035, representing a CAGR of 5% during the forecast period.
The pharmacy market is broadly segmented on the basis of Market by Distribution by type of Pharmacy, Product Offered, Availability, Drug Molecule, Therapeutic Area and Key Geographical Regions.
Revolutionizing pharmacy industry: unleashing the power of technological advancements.…
Global targeted drug delivery device market is anticipated to reach to USD $2,15 …
The prevalence of chronic diseases has increased significantly over the past few decades. Presently, around 129 million people in the US have at least one life threating chronic condition, such as heart disease, cancer, diabetes, obesity or hypertension.
The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period.
Additionally, about…
EMI shielding market Overview
Owing to the increasing reliant on electronic devices, the risk of electromagnetic interference (EMI) has grown. EMI occurs when electromagnetic waves generated by one device disrupt the operation of nearby electronic systems.
This interference can compromise device performance, reliability, and safety, making it a significant concern across various industries. To address this challenge, EMI shielding technologies have been developed. These involve the use of conductive or magnetic materials that either…
Biomanufacturing market is anticipated to reach to $12.0 billion by 2035with CAG …
Recognizing the potential of digitalization, biomanufacturers are increasingly adopting advanced platforms that enable operational excellence, enhance visibility, improve control, and synchronization across their bioprocessing operations
Biomanufacturing refers to a standardized process that utilizes microorganisms and other biological systems to produce and develop biomolecules as therapeutic modalities. Traditionally, the biopharmaceutical companies have hesitated to adopt cutting-edge digital technologies, such as cloud computing, artificial intelligence (AI), machine learning and internet of things (IoT),…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
